An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trial一种用于成人哮喘管理的抗炎缓解算法方法:一项开放标签、单臂试验eClinicalMedicineIF102025-10-210OAAI
Treatable trait guided asthma management: biomarker changes and responder analysisEUROPEAN RESPIRATORY JOURNALIF212023-10-271PRE
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammationPULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82022-08-016PRE
Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trialTHORAXIF7.72022-07-1811PRE
Potential Association Between Dietary Fibre and Humoral Response to the Seasonal Influenza VaccineFRONTIERS IN IMMUNOLOGYIF5.92021-11-179OAAI
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysisTHORAXIF7.72021-09-308OA
Systematic review of the comparison between adrenaline ( epinephrine) and selective β2-agonist in the setting of adults or children with acute asthmaEUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experimentTHORAXIF7.72020-07-2712OAAI
Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trialEUROPEAN RESPIRATORY JOURNALIF212020-05-225OAAI
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trialEUROPEAN RESPIRATORY JOURNALIF212020-02-0630OAAI
Late BreakingAbstract - Open-label trial of budesonide/formoterol reliever therapy in mild asthmaEUROPEAN RESPIRATORY JOURNALIF212019-11-212PRE
Discrete choice experiments identifying attributes influencing treatment preference in mild asthmaEUROPEAN RESPIRATORY JOURNALIF212019-11-212PRE
What do patients want? Preferences for two asthma regimens in mild/moderate asthmaEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trialLANCETIF88.52019-09-01188PREAI